fluorobenzenes has been researched along with Atrial Fibrillation in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abaci, O; Coskun, U; Kilickesmez, KO; Kocas, C; Oktay, V; Yigit, Z; Yildiz, A; Yildiz, CE | 1 |
| Dong, H; Li, S; Li, Y; Ma, B; Pang, Z; Wang, L; Wang, T; Yang, J | 1 |
| Abdul-Rahim, AH; Fulton, RL; Jhund, PS; Kjekshus, J; Latini, R; Lees, KR; Lip, GY; Maggioni, AP; McMurray, JJ; Perez, AC; Tavazzi, L; Tognoni, G; Wikstrand, J | 1 |
| Cosmi, F; Fabbri, G; Franzosi, MG; Latini, R; Lucci, D; Maggioni, AP; Marchioli, R; Nicolosi, GL; Porcu, M; Stefanelli, S; Tavazzi, L; Tognoni, G | 1 |
| Li, J; Qu, X; Song, Y; Xia, W; Yin, Z | 1 |
| Glynn, RJ; MacFadyen, J; Peña, JM; Ridker, PM | 1 |
| Feng, W; Li, J; Qu, X; Xia, W | 1 |
| Korantzopoulos, P; Li, G; Li, L; Liu, T | 1 |
| Kanorskiĭ, SG; Shevelev, VI | 1 |
| Adam, O; Böhm, M; Custodis, F; Frost, G; Laufs, U; Schäfers, HJ; Sussman, MA | 1 |
| Abdellah, AT; Clark, AL; Cleland, JG; Coletta, AP; Cullington, D; Rigby, AS | 1 |
| Bodrikova, VV; Kanorskaia, IuS; Kanorskiĭ, SG | 1 |
| Burge, J; Katz, RJ; Keefe, D; Laddu, AR; Somberg, JC; Steinberg, JS | 1 |
| Liem, LB; Peterson, J; Swerdlow, CD | 1 |
2 review(s) available for fluorobenzenes and Atrial Fibrillation
| Article | Year |
|---|---|
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; Biomarkers; Biphenyl Compounds; Cardiovascular Agents; Diabetes Mellitus, Type 1; Fatty Acids, Omega-3; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Proportional Hazards Models; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Rosuvastatin Calcium; Stroke; Stroke Volume; Sulfonamides; Tetrazoles | 2015 |
Preventive effects of rosuvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials.
Topics: Atrial Fibrillation; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides | 2013 |
5 trial(s) available for fluorobenzenes and Atrial Fibrillation
| Article | Year |
|---|---|
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2009 |
Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion.
Topics: Aged; Arginine; Atrial Fibrillation; Electric Countershock; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Recurrence; Rosuvastatin Calcium; Sulfonamides | 2009 |
High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.
Topics: Aged; Atrial Fibrillation; C-Reactive Protein; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2012 |
[Influence of perindopril, rosuvastatin, or omega-3 polyunsaturated fatty acids on efficacy of antirecurrence therapy with sotalol in patients with persistent atrial fibrillation].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Fatty Acids, Omega-3; Female; Fluorobenzenes; Follow-Up Studies; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Perindopril; Pyrimidines; Rosuvastatin Calcium; Secondary Prevention; Sotalol; Sulfonamides; Treatment Outcome | 2007 |
Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Female; Fluorobenzenes; Half-Life; Humans; Hypotension; Male; Middle Aged; Myocardial Contraction; Propanolamines; Time Factors | 1986 |
7 other study(ies) available for fluorobenzenes and Atrial Fibrillation
| Article | Year |
|---|---|
Comparison of rosuvastatin versus atorvastatin for preventing postoperative atrial fibrillation.
Topics: Atorvastatin; Atrial Fibrillation; Comorbidity; Coronary Artery Bypass; Coronary Artery Disease; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Premedication; Prevalence; Pyrimidines; Pyrroles; Retrospective Studies; Risk Assessment; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Turkey | 2013 |
[Efficacy and safety of circumferential pulmonary vein isolation with the anterior pulmonary vein vestibule intensive ablation and upstream therapy for atrial fibrillation].
Topics: Atrial Appendage; Atrial Fibrillation; Benzimidazoles; Benzoates; Catheter Ablation; Combined Modality Therapy; Fluorobenzenes; Heart Atria; Humans; Postoperative Period; Pulmonary Veins; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Telmisartan | 2014 |
Effects of rosuvastatin on serum asymmetric dimethylarginine levels and atrial structural remodeling in atrial fibrillation dogs.
Topics: Animals; Apoptosis; Arginine; Atrial Fibrillation; Atrial Function, Left; Dogs; Echocardiography, Transesophageal; Female; Fluorobenzenes; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardium; Nitric Oxide; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2012 |
[Antihypertensive therapy and dynamics of vascular wall rigidity in elderly patients with non-valvular atrial fibrillation].
Topics: Aged; Ankle Brachial Index; Anticholesteremic Agents; Antihypertensive Agents; Arterial Pressure; Arteries; Atrial Fibrillation; Combined Modality Therapy; Drug Monitoring; Female; Fluorobenzenes; Humans; Hypertension; Male; Myocardial Infarction; Perindopril; Pulse Wave Analysis; Pyrimidines; Rosuvastatin Calcium; Stroke; Sulfonamides; Tetrazoles; Treatment Outcome; Ultrasonography, Doppler, Duplex; Valine; Valsartan; Vascular Resistance | 2012 |
Role of Rac1 GTPase activation in atrial fibrillation.
Topics: Aged; Animals; Atrial Fibrillation; Collagen; Disease Models, Animal; Enzyme Activation; Female; Fluorobenzenes; GTP Phosphohydrolases; Heart Atria; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Transgenic; NADPH Oxidases; Pyrimidines; rac1 GTP-Binding Protein; Rosuvastatin Calcium; Sulfonamides; Up-Regulation | 2007 |
Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy.
Topics: Adrenergic beta-Antagonists; American Heart Association; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Pacing, Artificial; Clinical Trials as Topic; Fluorobenzenes; Heart Failure; Humans; Metoprolol; Pyrimidines; Rosuvastatin Calcium; Stem Cell Transplantation; Sulfonamides; United States | 2008 |
Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electrocardiography; Female; Fluorobenzenes; Humans; Isoproterenol; Male; Middle Aged; Propanolamines; Wolff-Parkinson-White Syndrome | 1988 |